High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli-Reference-Cited by-同舟云学术

High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli

Published:2013 Issue:1 Volume:12 Page:37
ISSN:1475-2859
Container-title:Microbial Cell Factories
language:en
Short-container-title:Microb Cell Fact

Author:

Nozach Hervé,Fruchart-Gaillard Carole,Fenaille François,Beau Fabrice,Ramos Oscar Henrique Pereira,Douzi Badreddine,Saez Natalie J,Moutiez Mireille,Servent Denis,Gondry Muriel,Thaï Robert,Cuniasse Philippe,Vincentelli Renaud,Dive Vincent

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference58 articles.

1. Venoms as a platform for human drugs: translating toxins into therapeutics

2. Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain

3. Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage

4. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

5. Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Cell Expression Systems for the Production of Recombinant Proteins for Immunodiagnosis and Immunoprophylaxis of Toxoplasmosis;Microorganisms;2024-08-22

2. A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders;PLOS ONE;2024-03-28

3. Preparation and self-cleavage of fusion soluble farnesyl diphosphate synthase in E. coli;Preparative Biochemistry & Biotechnology;2023-01-13

4. Recombinant production of growth factors for application in cell culture;iScience;2022-10

5. Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli;Molecular Biotechnology;2022-09-12